A Pre-Clinical MRI Solution to Quantitatively Map Gadolinium Nanoparticles for Radiotherapy Enhancement Studies - Université Claude Bernard Lyon 1 Accéder directement au contenu
Poster De Conférence International Journal of Radiation Oncology, Biology, Physics Année : 2019

A Pre-Clinical MRI Solution to Quantitatively Map Gadolinium Nanoparticles for Radiotherapy Enhancement Studies

Résumé

Gadolinium nanoparticles (GdNPs) have been used in image-guided radiotherapy and as radiosensitisers in radiation therapy. To understand the full potential of the pre-clinical study of GdNPs in radiotherapy, accurate localisation and quantification of NP concentration are crucial. This research was carried out to optimise pre-clinical MRI imaging parameters and characterise MRI performance for the quantification of GdNP concentration that is currently under investigation for radiotherapy enhancement.

Dates et versions

hal-02363535 , version 1 (14-11-2019)

Identifiants

Citer

P. Chaipanichkul, B. Siow, G. Royle, Olivier Tillement, K. Ricketts. A Pre-Clinical MRI Solution to Quantitatively Map Gadolinium Nanoparticles for Radiotherapy Enhancement Studies. Amercian Society for Radiation Oncology 61st Annual Meeting, Sep 2019, Chicago, United States. 105 (1), pp.E779, 2019, ⟨10.1016/j.ijrobp.2019.06.736⟩. ⟨hal-02363535⟩
14 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More